NORTION Compound Steep Pulse Therapeutic Apparatus

Technical Principle

NORTlON Compound Steep Pulse Therapeutic Apparatus employs Irreversible Electroporation (IRE) mechanism, delivering microsecond-level, bipolar positive/negative, high-intensity composite pulses to solid tumors. This induces tumor cell apoptosis through irreversible electroporation while simultaneously activating the body's anti-tumor immune response.

Applications

  • 1

    Recommended for ablation therapy in adult male patients with low- to intermediate-risk localized prostate cancer meeting all criteria:

    · PSA<20 ng/mL

    · Clinical stage T1a-T2c

    · Gleason Score ≤7 (Grade Group 2 per ISUP 2014)

  • 2

    Recommended for relieving lower urinary tract symptoms (LUTS) in male patients with benign prostatic hyperplasia (BPH) meeting all criteria:

    · Age ≥50 years

    · International Prostate Symptom Score (IPSS) ≥12

    · Prostate volume ≥30 cm³

Product Advantages

High-Frequency Irreversible Electroporation (H-FIRE, a new-generation IRE technology)

therapeutic device features four significant advantages.

More Complete Ablation

Well-Demarcated Boundaries

Induces near-total cellular apoptosis (≈100%) within the ablation zone

Urinary Continence

Tissue-Selective Ablation

Clinically Prevents Urethral Trauma and Nerve Injury to Continence-Governed Structures

Sexual Function

Precision Preservation of Sexual Function via Clinically Insignificant Impact on Neurovascular Structures

Ultra-Minimally Invasive

Streamlined Operation

Short Procedure Time

Minimal Bleeding & Complications

CSCO Prostate Cancer Diagnosis and Treatment Guidelines 2024

  • Anterior
    Placement

    Intermediate-Risk Localized

    Grade Group2(CSCO 2B)
  • Additional
    Option

    Low-Risk Localized

    Grade Group3(CSCO 3B)
  • Anterior
    Placement

    Low-Risk Localized

    Grade Group3(CSCO 3B)
  • Additional
    Option

    Recurrence After Definitive Radiotherapy

    PSADT< 9months

    Grade Group3(CSCO 3B)

  • Additional
    Option

    Recurrence After Definitive Radiotherapy

    PSADT> 9months

    Grade Group2(CSCO 3B)

Product Configuration

No.ComponentSpecifications
1DisplayDisplays User Interface
2Emergency Stop SwitchControls High-Voltage Circuits of Composite Steep Pulse Therapeutic Device
3Computer Power SwitchControls startup/shutdown
4Electrode NeedlesDeliver therapeutic pulses
5Medical KeyboardSoftware Parameter Configuration & Functional Button Control
6HandrailFacilitates Movement of Composite Steep Pulse Therapeutic Device
7Electrode PortConnect Electrode Needles to Deliver Therapeutic Pulses
8CastorsFacilitates Secure Mobility and Positioning of Composite Steep Pulse Therapeutic Device
9FootswitchConnects to Footswitch for Pulse Delivery Initiation and Termination